Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4+ stem cells into the ischaemic heart

Cardiovascular Research

Volumn 90, Issue 3, 2011, Pages 529-537

  Huber, Bruno C ^a   Brunner, Stefan ^a   Segeth, Alexander ^a   Nathan, Petra ^a   Fischer, Rebekka ^a   Zaruba, Marc M ^a   Vallaster, Marcus ^a   Theiss, Hans D ^a   David, Robert ^a   Gerbitz, Armin ^b   Franz, Wolfgang Michael ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Parathyroid hormone; Regenerative medicine; SDF 1 CXCR4; Stem cells

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; DIPEPTIDYL PEPTIDASE IV; GREEN FLUORESCENT PROTEIN; PLERIXAFOR; RECOMBINANT PARATHYROID HORMONE; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL HOMING; CELL MIGRATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFICACY; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART PROTECTION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL MOBILIZATION; TREATMENT OUTCOME;

ADULT STEM CELLS; ANIMALS; CARDIOTONIC AGENTS; CHEMOKINE CXCL12; DIPEPTIDYL PEPTIDASE 4; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HETEROCYCLIC COMPOUNDS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIAL ISCHEMIA; PARATHYROID HORMONE; PROTEASE INHIBITORS; RECEPTORS, CXCR4; REGENERATIVE MEDICINE;

EID: 79957455928     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr014     Document Type: Article

References (42)

1. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003;425:841-846. (Pubitemid 37351468)
2. Shimizu E, Selvamurugan N, Westendorf JJ, Partridge NC. Parathyroid hormone regulates histone deacetylases in osteoblasts. Ann N Y Acad Sci 2007;1116:349-353. (Pubitemid 350274330)
3. Adams GB, Martin RP, Alley IR, Chabner KT, Cohen KS, Calvi LM et al. Therapeutic targeting of a stem cell niche. Nat Biotechnol 2007;25:238-243. (Pubitemid 46227124)
4. Brunner S, Theiss HD, Murr A, Negele T, Franz WM. Primary hyperparathyroidism is associated with increased circulating bone marrow-derived progenitor cells. Am J Physiol Endocrinol Metab 2007;293:E1670-1675. (Pubitemid 350255118)
5. Brunner S, Zaruba MM, Huber B, David R, Vallaster M, Assmann G et al. Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow. Exp Hematol 2008;36:1157-1166.
6. Assmus B, Honold J, Schachinger V, Britten MB, Fischer-Rasokat U, Lehmann R et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006;355:1222-1232. (Pubitemid 44427446)
7. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: The scientific foundations of cardiac repair. J Clin Invest 2005;115:572-583. (Pubitemid 40322227)
8. Orlic D, Hill JM, Arai AE. Stem cells for myocardial regeneration. Circ Res 2002;91: 1092-1102. (Pubitemid 36076357)
9. Brunner S, Engelmann MG, Franz WM. Stem cell mobilisation for myocardial repair. Expert Opin Biol Ther 2008;8:1675-1690.
10. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001;98:10344-10349. (Pubitemid 32803022)
11. Ohtsuka M, Takano H, Zou Y, Toko H, Akazawa H, Qin Y et al. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. Faseb J 2004;18:851-853.
12. Deindl E, Zaruba MM, Brunner S, Huber B, Mehl U, Assmann G et al. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. Faseb J 2006;20:956-958.
13. Engelmann MG, Theiss HD, Hennig-Theiss C, Huber A, Wintersperger BJ, Werle-Ruedinger AE et al. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: Final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J Am Coll Cardiol 2006;48:1712-1721. (Pubitemid 44528196)
14. Zohlnhofer D, Ott I, Mehilli J, Schomig K, Michalk F, Ibrahim T et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: A randomized controlled trial. J Am Med Assoc 2006;295:1003-1010.
15. Levesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption of the CXCR4/ CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003;111:187-196. (Pubitemid 36105917)
16. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10:858-864. Epub 2004 Jul 2004. (Pubitemid 39070860)
17. Crump MP, Gong JH, Loetscher P, Rajarathnam K, Amara A, Arenzana-Seisdedos F et al. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J 1997;16:6996-7007. (Pubitemid 27520800)
18. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003;362:697-703. (Pubitemid 37101067)
19. Franz WM, Zaruba M, Theiss H, David R. Stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003;362:675-676. (Pubitemid 37101060)
20. Balas B, Baig MR,Watson C, Dunning BE, Ligueros-Saylan M,Wang Y et al. The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients. J Clin Endocrinol Metab 2007;92:1249-1255. (Pubitemid 46556394)
21. Christopherson KW, Hangoc G, Mantel CR, Broxmeyer HE. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 2004;305:1000-1003. (Pubitemid 39071774)
22. Christopherson KW, Hangoc G, Broxmeyer HE. Cell surface peptidase CD26/dipeptidylpeptidase IV regulatesCXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. J Immunol 2002;169:7000-7008. (Pubitemid 36899288)
23. Durinx C, Lambeir AM, Bosmans E, Falmagne JB, Berghmans R, Haemers A et al. Molecular characterization of dipeptidyl peptidase activity in serum: Soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides. Eur J Biochem 2000;267:5608-5613.
24. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-1441. (Pubitemid 32402100)
25. Zaruba MM, Huber BC, Brunner S, Deindl E, David R, Fischer R et al. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival. Cardiovasc Res 2008;77:722-731. (Pubitemid 351301860)
26. Huber BC, Fischer R, Brunner S, Groebner M, Rischpler C, Segeth A et al. Comparison of parathyroid hormone and G-CSF treatment after myocardial infarction on perfusion and stem cell homing. Am J Physiol Heart Circ Physiol 2010;298:H1466-H1471.
27. Schaefer BC, Schaefer ML, Kappler JW, Marrack P, Kedl RM. Observation of antigendependentCD8+ T-cell/ dendritic cell interactions in vivo. Cell Immunol 2001;214:110-122. (Pubitemid 34499465)
28. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004;110:3300-3305. (Pubitemid 39557491)
29. Scharpe S, De Meester I, Vanhoof G, Hendriks D, van Sande M, Van Camp K et al. Assay of dipeptidyl peptidase IV in serum by fluorometry of 4-methoxy-2- naphthylamine. Clin Chem 1988;34:2299-2301. (Pubitemid 19001258)
30. Lips DJ, Nagel TVD, Steendijk P, Palmen M, Janssen BJ, Dantzig J-M et al. Left ventricular pressure-volume measurements in mice: Comparison of closed-chest versus open-chest approach. Basic Res Cardiol 2004;99:351-359. (Pubitemid 39236725)
31. Abdel-Latif A, Bolli R, Zuba-Surma EK, Tleyjeh IM, Hornung CA, Dawn B. Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: A systematic review and meta-analysis of randomized controlled trials. Am Heart J 2008;156:216-226.e9.
32. Smart N, Riley PR. The stem cell movement. Circ Res 2008;102:1155-1168.
33. Segers VF, Tokunou T, Higgins LJ, MacGillivray C, Gannon J, Lee RT. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 2007;116:1683-1692. (Pubitemid 47537842)
34. Zaruba MM, Theiss HD, Vallaster M, Mehl U, Brunner S, David R et al. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell 2009;4:313-323.
35. Seeger FH, Rasper T, Koyanagi M, Fox H, Zeiher AM, Dimmeler S. CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia. Arterioscler Thromb Vasc Biol 2009;29:1802-1809.
36. Jung Y, Wang J, Schneider A, Sun YX, Koh-Paige AJ, Osman NI et al. Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing. Bone 2006;38:497-508.
37. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci 2001;938: 221-229; discussion 229-230.
38. Broxmeyer HE, Orschell CM, Clapp DW, Hangoc G, Cooper S, Plett PA et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005;201:1307-1318. (Pubitemid 40629073)
39. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-668. Epub 2004 Mar 2021. (Pubitemid 38524810)
40. Schuster MD, Kocher AA, Seki T, Martens TP, Xiang G, Homma S et al. Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration. Am J Physiol Heart Circ Physiol 2004;287:H525-H532. (Pubitemid 38955280)
41. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004;428:668-673. Epub 2004 Mar 2021. (Pubitemid 38524811)
42. Tastan I, Schreckenberg R, Mufti S, Abdallah Y, Piper HM, Schluter KD. Parathyroid hormone improves contractile performance of adult rat ventricular cardiomyocytes at low concentrations in a non-acute way. Cardiovasc Res 2009;82:77-83.